All the MEPs in the European Parliament’s environment and public health committee have acknowledged that the difficulty of accessing certain medicines in Europe is a subject of concern.
The right and left of the political spectrum are, however, largely divided over the way to resolve the situation, as borne out by the debate held on 12 October.
At the core of this discussion is the question of the own initiative report by Soledad Cabezón Ruiz MEP (S&D, Spain) on the European Union’s...